1/31/25 16:59 | 1/30/25 | DBVT | Health | BioPrd | Biological Products, (No Diag | Mohideen Pharis | I0 | O | Chief Me | S | -1 | 0.8500 | 0 | -1 | -1 | 111 | D | | | | | | | | | | | | | | |
11/27/24 16:15 | 11/22/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Mohideen Pharis | I0 | O | Chief Me | S.m | -1 | 0.5549 | 0 | -1 | -1 | 111 | D | | | | | | | | | | | | | | |
11/25/24 17:13 | 11/21/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Mohideen Pharis | I0 | O | Chief Me | S.d | -1 | 0.5400 | 0 | -2 | -2 | 112 | D | | | | | | | | | | | | | | |
7/31/24 17:32 | 7/29/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Mohideen Pharis | I0 | O | Chief Me | S | -2 | 0.9800 | 0 | -2 | -2 | 79 | D | | | | | | | | | | | | | | |
5/29/24 16:15 | 5/22/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Mohideen Pharis | I0 | O | Chief Me | S.m | -1 | 1.37 | 0 | -1 | -1 | 81 | D | | | | | | | | | | | | | | |
3/11/24 16:15 | 3/8/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Tasse Daniel | I0 | DO | CEO | P | 14 | 0.8300 | 0 | 17 | New | 17 | D | | | | | | | | | | | | | | |
2/8/24 17:02 | 2/6/24 | DBVT | Health | BioPrd | Biological Products, (No Diag | Ndu Adora | I0 | D | | P | 2 | 0.8900 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
12/19/23 16:44 | 11/22/23 | DBVT | Health | BioPrd | Biological Products, (No Diag | Mohideen Pharis | I0 | O | Chief Me | S | -4 | 1.74 | 0 | -2 | -3 | 82 | D | | | | | | | | | | | | | | |
8/28/23 16:35 | 8/25/23 | DBVT | Health | BioPrd | Biological Products, (No Diag | Morris Timothy E | I0 | D | | P | 18 | 1.52 | 0 | 12 | New | 12 | D | | | | | | | | | | | | | | |
8/14/23 16:32 | 11/24/22 | DBVT | Health | BioPrd | Biological Products, (No Diag | Mohideen Pharis | I0 | O | Chief Me | S.dm | -7 | 3.02 | 0 | -2 | -4 | 49 | D | | | | | | | | | | | | | | |
8/3/23 16:40 | 8/1/23 | DBVT | Health | BioPrd | Biological Products, (No Diag | Soland Daniel B | I0 | D | | P | 24 | 1.62 | 0 | 15 | 300 | 20 | D | | | | | | | | | | | | | | |